---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-004459"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T05:41:58.722832+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience receives $1M bridge loan from CEO John Payne with 10% interest and warrants

## Summary
- CEO John Payne provides $1M unsecured six-month loan at 10% simple interest, extendable six months.
- Warrants to purchase 390,000 shares at $2.91 per share, exercisable for three years.
- Proceeds for working capital, coccidiosis validation study in broiler chickens, and strategic alternatives.
- Company expects to complete titration study in May 2023, then 42-day study in over 2,000 chickens by mid-2023.

## SEC filing metadata
- accession: 0001654954-23-004459
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495423004459/0001654954-23-004459-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495423004459/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-004459
- JSON: https://secwatch.observer/filing/0001654954-23-004459.json
- Plain text: https://secwatch.observer/filing/0001654954-23-004459.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.